anti-Tumor Suppressor Candidate 2 (TUSC2) Anticorps

TUSC2 is a highly conserved lung cancer candidate gene. De plus, nous expédions Tumor Suppressor Candidate 2 Protéines (4) et Tumor Suppressor Candidate 2 Kits (2) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
TUSC2 11334 O75896
TUSC2 80385 Q9WVF8
TUSC2 501052  
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-Tumor Suppressor Candidate 2 Anticorps sur anticorps-enligne.fr

Showing 10 out of 59 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Fournisseur Livraison Prix Détails
Humain Chèvre Inconjugué ELISA   100 μg Connectez-vous pour afficher 6 to 7 Days
$291.53
Détails
Humain Lapin Inconjugué ELISA, WB Western blot analysis of extracts from HeLa cells, using TUSC2 Antibody. The lane on the right is treated with the synthesized peptide. 100 μg Connectez-vous pour afficher 2 to 3 Days
$302.50
Détails
Humain Lapin Inconjugué ELISA, IHC, WB 100 μL Connectez-vous pour afficher 16 Days
$181.73
Détails
Humain Lapin Inconjugué IF/ICC, IHC, WB Immunohistochemistry of paraffin-embedded rat brain using TUSC2 antibody (ABIN5974256) at dilution of 1/200 (40x lens). Immunohistochemistry of paraffin-embedded mouse kidney using TUSC2 antibody (ABIN5974256) at dilution of 1/200 (40x lens). 100 μL Connectez-vous pour afficher 11 to 16 Days
$426.40
Détails
Humain Lapin Inconjugué ELISA, ICC, IF, WB ABIN6266823 staining HeLa by IF/ICC. The sample were fixed with PFA and permeabilized in 0.1% Triton X-100,then blocked in 10% serum for 45 minutes at 25°C. The primary antibody was diluted at 1/200 and incubated with the sample for 1 hour at 37°C. An Alexa Fluor 594 conjugated goat anti-rabbit IgG (H+L) Ab, diluted at 1/600, was used as the secondary antibody. Western blot analysis on HeLa cell lysate using TUSC2 Antibody,The lane on the left is treated with the antigen-specific peptide. 100 μL Connectez-vous pour afficher 11 to 12 Days
$390.77
Détails
Humain Lapin Inconjugué IF, IHC, WB Immunohistochemistry of paraffin-embedded rat brain using TUSC2 antibody at dilution of 1:200 (40x lens). Immunohistochemistry of paraffin-embedded mouse kidney using TUSC2 antibody at dilution of 1:200 (40x lens). 100 μL Connectez-vous pour afficher 16 Days
$366.77
Détails
Humain Lapin Inconjugué ELISA, IHC, IHC (p), WB Human Thyroid: Formalin-Fixed, Paraffin-Embedded (FFPE) 50 μL Connectez-vous pour afficher 11 to 14 Days
$484.00
Détails
Humain Chèvre Inconjugué ELISA   0.1 mg Connectez-vous pour afficher 2 to 3 Days
$446.88
Détails
Humain Lapin Inconjugué IF, IHC Immunohistochemistry of paraffin-embedded rat brain using TUSC2 antibody. Immunohistochemistry of paraffin-embedded mouse kidney using TUSC2 antibody. 200 μL Connectez-vous pour afficher 12 to 14 Days
$438.90
Détails
Humain Souris Inconjugué ELISA, WB Western Blot detection against Immunogen (34.91 KDa) . 50 μL Connectez-vous pour afficher 11 to 12 Days
$305.71
Détails

anti-Tumor Suppressor Candidate 2 Anticorps mieux référencés

  1. Human Polyclonal TUSC2 Primary Antibody pour ELISA - ABIN451824 : Deng, Kawashima, Wu, Jayachandran, Xu, Minna, Roth, Ji et al.: Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent ... dans Cancer research 2007 (PubMed)

Plus d’anticorps contre Tumor Suppressor Candidate 2 partenaires d’interaction

Human Tumor Suppressor Candidate 2 (TUSC2) interaction partners

  1. TUSC2P can suppresses the tumor function of esophageal squamous cell carcinoma by regulating TUSC2 expression and may also serve as a prognostic factor for esophageal squamous cell carcinoma patients.

  2. these findings show that the combination of TUSC2-erlotinib induces additional novel vulnerabilities that can be targeted with Auranofin.

  3. Data show that TUSC2 is a direct target of miR-584, which is transcriptionally regulated by TWIST1.

  4. FOXP1, TP53INP1, TNFAIP3, and TUSC2 were identified as miR-19a targets.

  5. The therapeutic activity of TUSC2 could extend the use of erlotinib to lung cancer patients with wildtype EGFR.

  6. TUSC2P and TUSC2 3'-UTR expression inhibits cell proliferation, survival, migration, invasion and colony formation, and increases tumor cell death. TUSC2P and TUSC2 3'-UTR bind to miRNAs and arrest their functions, leading to increased TUSC2 translation.

  7. The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner.

  8. RNA sequence elements in FUS1 UTRs that regulate FUS1 protein express were identified.

  9. Absence of tumor suppressor FUS1 protein expression is associated with bone and soft tissue sarcomas.

  10. Data show that the recombinant FUS1 plasmid has been successfully cloned, which allows highly efficient FUS1 expression in E.coli strain Rosetta (DE3)2 plys.

  11. The goal of this study was to analyze possible involvement of TUSC2 in malignant pleural mesothelioma.

  12. Myristoylation is required for Fus1-mediated tumor-suppressing activity and suggest a novel mechanism for the inactivation of tumor suppressors in lung cancer.

  13. These results suggest that miR-378 enhances cell survival, tumor growth, and angiogenesis through repression of the expression of two tumor suppressors, Sufu and Fus-1.

  14. FUS1 gene and Fus1 protein abnormalities could be used to develop new strategies for molecular cancer therapy for a significant subset of lung tumors.

  15. These results suggest that the three miRNAs are negative regulators of Fus1 expression in lung cancers.

  16. Overexpression of candidate tumor suppressor geneFUS1 isolated from the 3p21.3 homozygous deletionregion leads to G1 arrest and growth inhibition oflung cancer cells.

Mouse (Murine) Tumor Suppressor Candidate 2 (TUSC2) interaction partners

  1. results suggest that Tusc2 acts as a positive regulator of RANKL-mediated osteoclast differentiation

  2. Fus1 achieves its protective role in inflammation, autoimmunity, and cancer via the regulation of mitochondrial calcium and calcium-coupled parameters.

Tumor Suppressor Candidate 2 (TUSC2) profil antigène

Profil protéine

This gene is a highly conserved lung cancer candidate gene. No other information about this gene is currently available.

Gene names and symbols associated with TUSC2

  • tumor suppressor candidate 2 (TUSC2) anticorps
  • tumor suppressor candidate 2 L homeolog (tusc2.L) anticorps
  • tumor suppressor candidate 2 (Tusc2) anticorps
  • tumor suppressor candidate 2b (tusc2b) anticorps
  • 1190001E22Rik anticorps
  • AA407686 anticorps
  • C3orf11 anticorps
  • Fus1 anticorps
  • Lgcc anticorps
  • PAP anticorps
  • Pdap2 anticorps
  • TUSC2 anticorps
  • zgc:92701 anticorps

Protein level used designations for TUSC2

PDGFA associated protein 2 , PDGFA-associated protein 2 , fus-1 protein , fusion 1 protein , tumor suppressor candidate 2 , lung cancer candidiate, FUS

GENE ID SPECIES
11334 Homo sapiens
702614 Macaca mulatta
100137709 Xenopus laevis
80385 Mus musculus
501052 Rattus norvegicus
608576 Canis lupus familiaris
448842 Sus scrofa
100848754 Bos taurus
436675 Danio rerio
Fournisseurs de qualité sélectionnés pour anti-Tumor Suppressor Candidate 2 (TUSC2) Anticorps
Avez-vous cherché autre chose?